McIlrath & Eck’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
Other funds holding BHC
IC
GAM
PC
MRCP
McIlrath & Eck's BHC Position: Q1 2025 in Review
McIlrath & Eck sold out of Bausch Health (BHC) in Q1 2025, closing a stake of 72 shares — an estimated $580 sold.
McIlrath & Eck first reported a position in BHC in Q3 2018 and held it in 26 quarters. The position peaked at $21K in Q1 2021. 230 funds tracked by Wall St. Rank hold BHC as of Q1 2025.
- McIlrath & Eck reported no remaining Bausch Health position as of Q1 2025 after selling out during the quarter.
- McIlrath & Eck sold 72 Bausch Health shares in Q1 2025, an estimated $580.
- McIlrath & Eck first reported a position in Bausch Health in Q3 2018 and held it in 26 quarters.
- McIlrath & Eck's Bausch Health position peaked at $21K in Q1 2021.
- 230 funds tracked by Wall St. Rank held Bausch Health as of Q1 2025.
Based on McIlrath & Eck's 13F filing for Q1 2025, filed 16 May 2025.